A detailed history of Northstar Group, Inc. transactions in Becton Dickinson & CO stock. As of the latest transaction made, Northstar Group, Inc. holds 1,686 shares of BDX stock, worth $385,234. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,686
Previous 1,686 -0.0%
Holding current value
$385,234
Previous $394,000 3.05%
% of portfolio
0.07%
Previous 0.07%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 17, 2024

SELL
$225.07 - $246.17 $5,626 - $6,154
-25 Reduced 1.46%
1,686 $394,000
Q4 2023

Jan 10, 2024

BUY
$232.24 - $267.23 $232 - $267
1 Added 0.06%
1,711 $417,000
Q1 2023

Apr 27, 2023

SELL
$229.71 - $259.35 $229 - $259
-1 Reduced 0.06%
1,710 $423,000
Q4 2022

Jan 25, 2023

SELL
$218.29 - $256.91 $4,365 - $5,138
-20 Reduced 1.16%
1,711 $0
Q3 2022

Oct 26, 2022

BUY
$51.03 - $264.23 $6,889 - $35,671
135 Added 8.46%
1,731 $386,000
Q4 2021

Jan 31, 2022

SELL
$230.08 - $250.94 $314,059 - $342,533
-1,365 Reduced 46.1%
1,596 $401,000
Q3 2021

Nov 02, 2021

SELL
$232.72 - $256.47 $5,818 - $6,411
-25 Reduced 0.84%
2,961 $728,000
Q4 2019

Jan 21, 2020

SELL
$236.45 - $266.82 $8,275 - $9,338
-35 Reduced 1.16%
2,986 $812,000
Q3 2019

Nov 01, 2019

SELL
$230.58 - $256.08 $35,048 - $38,924
-152 Reduced 4.79%
3,021 $764,000
Q2 2019

Jul 12, 2019

SELL
$217.4 - $246.08 $10,870 - $12,304
-50 Reduced 1.55%
3,173 $800,000
Q2 2018

Jul 27, 2018

BUY
$208.1 - $233.85 $1,872 - $2,104
9 Added 0.28%
3,223 $772,000
Q1 2018

Apr 13, 2018

BUY
$205.46 - $240.27 $41,502 - $48,534
202 Added 6.71%
3,214 $696,000
Q4 2017

Jan 23, 2018

BUY
$189.0 - $222.64 $1,701 - $2,003
9 Added 0.3%
3,012 $645,000
Q3 2017

Oct 16, 2017

BUY
$186.89 - $198.9 $561,230 - $597,296
3,003
3,003 $589,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65.2B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Northstar Group, Inc. Portfolio

Follow Northstar Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northstar Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Northstar Group, Inc. with notifications on news.